CAS 1791420-09-1

Dilpacimab

CAS: 1791420-09-1

A humanized dual-variable domain antibody targets both delta-like ligand 4 (DLL4) and VEGF pathways

Ref: 3D-CLA1529

Dilpacimab

CAS: 1791420-09-1

Dilpacimab (ABT165) is a dual-variable antibody that targets DLL4 and VEGF pathways, showing potential in cancer research by blocking angiogenesis and Notch.

Purity: 95% - 97.7% (SDS-PAGE); 95.6% (SEC-HPLC)

Color and Shape: Liquid

Ref: TM-T77157